Dupixent can be used for several conditions, once of which is treating ongoing nasal and sinus inflammation due to nasal polyps. It can be used for both adults and certain children. Dupixent is an ...

Researchers conducted an indirect treatment comparison (Bucher method) using placebo as a common comparator to evaluate the efficacy of dupilumab and tezepelumab in patients with CRSwNP. The analysis ...

Which nasal decongestant is best? Whether you’re stuffed up from allergies or are dealing with the common cold, the best nasal decongestants help reduce the symptoms of a stuffy nose. These medicines ...

‘Tis the season of sniffles and sinus issues. But experts say there are ways to get relief. “Sinuses are pockets of air inside our facial skeleton that produce mucus throughout the day. There are ...

Tezspire (tezepelumab-ekko) is a prescription medicine used to treat inflammatory conditions of the airways, such as severe asthma. The FDA has now approved it as an add-on treatment for adults and ...

“It has a huge, huge impact on almost every facet of life,” says Duncan Boak. “Not being able to breathe properly. Being bunged up all the time. Blowing your nose constantly, snot running out of your ...

LOS ANGELES (KABC) -- One in eight U.S. adults struggle to breathe and battle the persistent pain and discomfort of chronic sinusitis. Even with sprays, irrigations and pills, a staggering 80% of ...

Surgery is typically a last resort for people with a chronically blocked or runny nose. But in some cases, it may actually work better than the antibiotics that are routinely prescribed to treat the ...

Please provide your email address to receive an email when new articles are posted on . Nasal polyp and congestion scores dropped more with stapokibart vs. placebo. Overall nasal symptoms, sense of ...

Addition of the monoclonal antibody stapokibart significantly improved nasal polyps and nasal congestion in adults with uncontrolled chronic rhinosinusitis with nasal polyps, based on new data from ...

About The Study: Among patients with severe chronic rhinosinusitis with nasal polyps treated with a daily intranasal corticosteroid, stapokibart, a novel monoclonal antibody, reduced polyp size and ...